Tech Company Financing Transactions
Deltanoid Pharmaceuticals Funding Round
Deltanoid Pharmaceuticals secured a $12 million Series B financing round on 12/18/2007. Investors included .
Transaction Overview
Company Name
Announced On
12/18/2007
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Series B
Investors
No investors have been recorded for this company.
Proceeds Purpose
Deltanoid plans to use the proceeds to advance its lead compounds and preclinical pipeline for therapies to treat patients with renal disease.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1603 Monroe St.
Madison, WI 53711
USA
Madison, WI 53711
USA
Phone
Website
Email Address
Overview
Deltanoid Pharmaceuticals Inc. is a privately funded biopharmaceutical company.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Hector DeLuca
Chief Scientific Officer
Lori Plum
Executive Vice President
Margaret Clagett-Dame
VP - Bus. Development
Linda Leikness
Browse more venture capital transactions:
Prev: 12/18/2007: Validus DC Solutions venture capital transaction
Next: 12/18/2007: Brill Street venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs